CN116370543A - Cattle yellow detoxification tablet and preparation method thereof - Google Patents

Cattle yellow detoxification tablet and preparation method thereof Download PDF

Info

Publication number
CN116370543A
CN116370543A CN202310427458.4A CN202310427458A CN116370543A CN 116370543 A CN116370543 A CN 116370543A CN 202310427458 A CN202310427458 A CN 202310427458A CN 116370543 A CN116370543 A CN 116370543A
Authority
CN
China
Prior art keywords
parts
tablet
detoxification
powder
bezoar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310427458.4A
Other languages
Chinese (zh)
Inventor
陈家进
唐颂豪
林丽丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANJING TONGRENTANG PHARMACEUTICAL CO Ltd
Original Assignee
NANJING TONGRENTANG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANJING TONGRENTANG PHARMACEUTICAL CO Ltd filed Critical NANJING TONGRENTANG PHARMACEUTICAL CO Ltd
Priority to CN202310427458.4A priority Critical patent/CN116370543A/en
Publication of CN116370543A publication Critical patent/CN116370543A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/413Gall bladder; Bile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/36Arsenic; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288Taraxacum (dandelion)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/346Platycodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/78Saururaceae (Lizard's-tail family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)

Abstract

The present application relates to the technical field of pharmaceutical formulations. In particular to a cattle yellow detoxification tablet and a preparation method thereof. The raw materials of the cattle yellow detoxification tablet comprise the following components in parts by weight: 3-8 parts of bezoar, 180-220 parts of gypsum, 130-170 parts of astragalus, 20-30 parts of borneol, 40-60 parts of realgar, 180-220 parts of rheum officinale, 80-120 parts of platycodon grandiflorum, 40-60 parts of liquorice, 20-40 parts of dandelion and 5-15 parts of cordate houttuynia extract. The dandelion and houttuynia cordata extracts are utilized in the application, so that the curative effect of the bezoar detoxification tablet on clearing heat and detoxifying can be improved, and the symptoms of muscular soreness of patients with excessive internal heat can be treated.

Description

Cattle yellow detoxification tablet and preparation method thereof
Technical Field
The application relates to the technical field of pharmaceutical preparations, in particular to a cattle yellow detoxification tablet and a preparation method thereof.
Background
The bezoar detoxicating tablet is prepared from eight traditional Chinese medicines of rhubarb, baical skullcap root, platycodon root, liquoric root, gypsum, artificial bezoar, borneol and realgar, has the efficacy of clearing heat and detoxicating, and is used for treating excessive internal heat, sore throat, gum swelling and pain, sores on the mouth and tongue and conjunctival congestion and swelling and pain. However, usually, the patients with excessive internal heat often have symptoms of muscular soreness, and the bezoar detoxification tablet has a single treatment effect and cannot treat other symptoms caused by excessive internal heat.
Disclosure of Invention
In order to diversify the treatment effect of the bezoar detoxification tablet, the application provides a bezoar detoxification tablet and a preparation method thereof.
In a first aspect, the present application provides a ox yellow detoxification tablet, which adopts the following technical scheme:
the raw materials of the cattle yellow detoxification tablet comprise the following components in parts by weight: 3-8 parts of bezoar, 180-220 parts of gypsum, 130-170 parts of astragalus, 20-30 parts of borneol, 40-60 parts of realgar, 180-220 parts of rheum officinale, 80-120 parts of platycodon grandiflorum, 40-60 parts of liquorice, 20-40 parts of dandelion and 5-15 parts of cordate houttuynia extract.
By adopting the technical scheme, the dandelion and houttuynia cordata extracts have good heat-clearing and detoxifying effects, and the efficacy of the bezoar detoxifying tablet can be further improved by adding the extracts into the bezoar detoxifying tablet; in addition, the extracts of dandelion and houttuynia cordata are added into the bezoar detoxification tablet, and the applicant has unexpectedly found that the bezoar detoxification tablet also has the effect of treating muscle soreness, so that the curative effect of the bezoar detoxification tablet is diversified.
In a specific embodiment, the preparation method of the houttuynia cordata extract comprises the following steps:
pulverizing herba Houttuyniae to obtain herba Houttuyniae powder, adding polyethoxy lauric acid and herbal tea alcohol into herba Houttuyniae powder, stirring, mixing, adding ethanol solution, stirring to obtain mixed solution, extracting in water bath, layering, concentrating supernatant, and drying to obtain herba Houttuyniae extract.
By adopting the technical scheme, the separation of active ingredients in the houttuynia cordata can be promoted by utilizing the polyethoxy lauric acid cool tea alcohol, so that the curative effect of the houttuynia cordata extract is improved.
In a specific embodiment, the mixed liquor water bath extraction temperature is 60-80 ℃ and the extraction time is 50-60min.
In a specific embodiment, the mass concentration of the polyethoxy lauric acid herbal tea alcohol in the mixed solution is 0.5-1.5g/L.
By adopting the technical scheme, the time and the temperature of water bath extraction and the consumption of the polyethoxy lauric acid cool tea alcohol are further limited, so that the extraction effect of the cordate houttuynia is improved.
In a second aspect, the preparation method of the cattle yellow detoxification tablet provided by the application adopts the following technical scheme:
a preparation method of a cattle yellow detoxification tablet comprises the following steps:
grinding radix et rhizoma Rhei, realgar, calculus bovis, and Borneolum Syntheticum into fine powder; decocting Gypsum Fibrosum, radix astragali, radix Platycodi, glycyrrhrizae radix and herba Taraxaci in water twice, filtering, mixing the filtrates, concentrating the filtrate to obtain fluid extract, adding radix et rhizoma Rhei powder, realgar powder and herba Houttuyniae extract, stirring, granulating, drying, adding calculus bovis powder and Borneolum Syntheticum powder, stirring, and tabletting to obtain tablet; spraying the coating solution on the tablet, and drying to obtain the detoxicating tablet.
By adopting the technical scheme, rheum officinale, realgar, bezoar and borneol are firstly ground into powder, then gypsum, astragalus, platycodon grandiflorum, liquorice and dandelion are decocted, the liquid is concentrated to obtain clear paste, rheum officinale powder and realgar powder are firstly added, granulating is carried out, bezoar powder and borneol powder are then added, tabletting is carried out, a tablet is obtained, and finally, the coating liquid is sprayed on the tablet, and the tablet is dried, so that the bezoar detoxification tablet with good curative effect is obtained.
In a specific embodiment, the preparation method of the coating liquid comprises the following steps:
sequentially adding acrylic resin and hypromellose into medicinal ethanol, stirring, adding titanium dioxide and magnesium stearate after the hypromellose is dissolved, and stirring and mixing to obtain coating solution.
In a specific embodiment, the weight ratio of the magnesium stearate, the titanium pigment, the hypromellose, the acrylic resin, and the ethanol is 1: (8-10): (10-20): (8-10): (80-120).
In a specific embodiment, gypsum Fibrosum, radix astragali, radix Platycodi, glycyrrhrizae radix, and herba Taraxaci are decocted with water twice for 1.5-2.5 hr.
In summary, the present application includes at least one of the following beneficial technical effects:
1. the dandelion and houttuynia cordata extracts have good heat-clearing and detoxifying effects, and the efficacy of the bezoar detoxifying tablet can be further improved by adding the extracts into the bezoar detoxifying tablet; in addition, the dandelion and houttuynia cordata extracts are added into the bezoar detoxification tablet, so that the applicant has unexpectedly found that the bezoar detoxification tablet also has the effect of treating muscle soreness, and therefore the curative effect of the bezoar detoxification tablet is diversified; 2. in the application, the herba houttuyniae is extracted by using the polyethoxy lauric acid herbal tea alcohol, so that the separation of active ingredients in the herba houttuyniae can be promoted, and the curative effect of the herba houttuyniae extract is improved;
3. grinding rheum officinale, realgar, bezoar and borneol, decocting gypsum, astragalus mongholicus, platycodon grandiflorum, liquorice and dandelion, concentrating the decoction to obtain clear paste, adding rheum officinale powder, realgar powder and houttuynia cordata extract, granulating, adding bezoar powder and borneol powder, tabletting to obtain a tablet, finally spraying coating liquid on the tablet, and drying to obtain the bezoar detoxication tablet with good curative effect.
Detailed Description
The present application is described in further detail below with reference to examples.
All the starting materials in the examples are commercially available. Wherein the titanium dioxide is medicinal titanium dioxide and the acrylic resin is acrylic resin IV.
Preparation example
Preparation example 1
Preparation example 1 provides a preparation method of a houttuynia cordata extract, which comprises the following steps:
pulverizing herba Houttuyniae to obtain herba Houttuyniae powder, adding polyethoxy lauric acid and herbal tea alcohol into herba Houttuyniae powder, stirring, mixing, adding 50% ethanol solution, stirring to obtain mixed solution, extracting in water bath at 60deg.C for 60min, layering, concentrating supernatant, and drying to obtain herba Houttuyniae extract; wherein the mass concentration of the polyethoxy lauric acid cool tea alcohol in the mixed solution is 0.5g/L; the weight ratio of the cordate houttuynia powder to the ethanol solution is 1:10.
preparation example 2
Preparation example 2 differs from preparation example 1 in that herba Houttuyniae is crushed to obtain herba Houttuyniae powder, polyethoxy lauric acid and tea alcohol are added into the herba Houttuyniae powder, stirring and mixing uniformly, 50% ethanol solution is added into the herba Houttuyniae powder, stirring uniformly to obtain mixed solution, water bath extraction is carried out at 70 ℃ for 55min, layering is carried out, and supernatant is concentrated and dried to obtain herba Houttuyniae extract; the remaining steps are identical to those of preparation 1.
Preparation example 3
Preparation example 3 differs from preparation example 1 in that herba Houttuyniae is crushed to obtain herba Houttuyniae powder, polyethoxy lauric acid and tea alcohol are added into the herba Houttuyniae powder, stirring and mixing uniformly, then 50% ethanol solution is added, stirring uniformly to obtain mixed solution, water bath extraction is carried out at 80 ℃ for 50min, layering is carried out, and supernatant is concentrated and dried to obtain herba Houttuyniae extract; the remaining steps are identical to those of preparation 1.
Preparation example 4
Preparation example 4 differs from preparation example 2 in that the mass concentration of the polyethoxy lauric acid herbal tea alcohol in the mixed solution is 1g/L; the remaining steps are identical to those of preparation 2.
Preparation example 5
Preparation example 5 differs from preparation example 2 in that the mass concentration of the polyethoxy lauric acid herbal tea alcohol in the mixed solution is 1.5g/L; the remaining steps are identical to those of preparation 2.
Preparation example 6
Preparation example 6 provides a preparation method of a houttuynia cordata extract, which comprises the following steps:
pulverizing herba Houttuyniae to obtain herba Houttuyniae powder, adding 50% ethanol solution into herba Houttuyniae powder, stirring to obtain mixed solution, extracting in water bath at 60deg.C for 60min, layering, concentrating supernatant, and drying to obtain herba Houttuyniae extract; wherein the weight ratio of the cordate houttuynia powder to the ethanol solution is 1:10.
preparation example 7
Preparation example 7 provides a preparation method of the coating liquid, which comprises the following steps:
sequentially adding acrylic resin and hypromellose into medicinal ethanol, stirring uniformly, adding titanium dioxide and magnesium stearate after the hypromellose is dissolved, and stirring uniformly to obtain coating liquid; wherein the weight ratio of magnesium stearate, titanium dioxide, hypromellose, acrylic resin and ethanol is 1:7:5:7:60.
preparation example 8
Preparation example 8 differs from preparation example 7 in that the weight ratio of magnesium stearate, titanium pigment, hypromellose, acrylic resin, and ethanol is 1:8:10:8:80; the remaining steps are identical to those of preparation 7.
Preparation example 9
Preparation example 9 differs from preparation example 7 in that the weight ratio of magnesium stearate, titanium pigment, hypromellose, acrylic resin, and ethanol is 1:9:15:9:100; the remaining steps are identical to those of preparation 7.
Preparation example 10
Preparation example 10 differs from preparation example 7 in that the weight ratio of magnesium stearate, titanium pigment, hypromellose, acrylic resin, and ethanol is 1:10:20:10:120; the remaining steps are identical to those of preparation 7.
PREPARATION EXAMPLE 11
Preparation 11 differs from preparation 7 in that the weight ratio of magnesium stearate, titanium pigment, hypromellose, acrylic resin, and ethanol is 1:11:25:11:140; the remaining steps are identical to those of preparation 7.
Examples
Example 1
Example 1 provides a preparation method of a cattle yellow detoxification tablet, comprising the following steps:
grinding 180g of rheum officinale, 40g of realgar, 3g of bezoar and 20g of borneol into fine powder; decocting 180g of gypsum, 130g of astragalus, 80g of platycodon grandiflorum, 40g of liquorice and 20g of dandelion with water twice for 2 hours each time, filtering, combining the two filtrates, concentrating the filtrate into clear paste, adding rhubarb powder, realgar powder and 5kg of cordate houttuynia extract in preparation example 1, uniformly stirring, granulating, drying, adding bezoar powder and borneol powder, uniformly stirring, and tabletting to obtain plain tablets; spraying the coating solution in preparation example 7 on plain tablet, and drying to obtain detoxicating tablet.
Examples 2 to 6
Examples 2-6 differ from example 1 in the choice of houttuynia cordata extract, as detailed in Table 1.
TABLE 1 selection of houttuynia cordata extract
Figure BDA0004189066810000041
Figure BDA0004189066810000051
Examples 7 to 10
Examples 7-10 differ from example 4 in the choice of coating solution, as detailed in Table 2.
Table 2 selection of coating solutions
Sample of Coating liquid is selected
Example 4 Preparation example 7
Example 7 Preparation example 8
Example 8 Preparation example 9
Example 9 Preparation example 10
Example 10 PREPARATION EXAMPLE 11
Example 11
Example 11 provides a method for preparing a cattle yellow detoxification tablet, comprising the following steps:
grinding 200g of rheum officinale, 50g of realgar, 5g of bezoar and 25g of borneol into fine powder; decocting 200g of gypsum, 150g of astragalus, 100g of platycodon grandiflorum, 50g of liquorice and 30g of dandelion with water for 2 hours each time, filtering, combining the two filtrates, concentrating the filtrate into clear paste, adding rhubarb powder, realgar powder and 10kg of houttuynia cordata extract in preparation example 4, uniformly stirring, granulating, drying, adding bezoar powder and borneol powder, uniformly stirring, and tabletting to obtain plain tablets; spraying the coating solution in preparation example 9 on plain tablet, and drying to obtain detoxicating tablet.
Example 12
Example 12 provides a method for preparing a cattle yellow detoxification tablet, comprising the following steps:
grinding 220g of rheum officinale, 60g of realgar, 8g of bezoar and 30g of borneol into fine powder; decocting 220g of gypsum, 170g of astragalus, 120g of platycodon grandiflorum, 60g of liquorice and 40g of dandelion with water twice for 2 hours each time, filtering, combining the two filtrates, concentrating the filtrate into clear paste, adding rhubarb powder, realgar powder and 15kg of cordate houttuynia extract in preparation example 4, uniformly stirring, granulating, drying, adding bezoar powder and borneol powder, uniformly stirring, and tabletting to obtain plain tablets; spraying the coating solution in preparation example 9 on plain tablet, and drying to obtain detoxicating tablet.
Comparative example
Comparative example 1
Comparative example 1 provides a preparation method of a cattle yellow detoxification tablet, comprising the following steps:
grinding 185g of rheum officinale, 40g of realgar, 3g of bezoar and 20g of borneol into fine powder; decocting 190g of gypsum, 135g of astragalus, 85g of platycodon grandiflorum and 40g of liquorice with water twice for 2 hours each time, filtering, combining the two filtrates, concentrating the filtrate into clear paste, adding rhubarb powder and realgar powder, uniformly stirring, granulating, drying, adding bezoar powder and borneol powder, uniformly stirring, and tabletting to obtain a plain tablet; spraying the coating solution in preparation example 7 on plain tablet, and drying to obtain detoxicating tablet.
Comparative example 2
Comparative example 2 provides a preparation method of a cattle yellow detoxification tablet, comprising the following steps:
grinding 185g of rheum officinale, 40g of realgar, 3g of bezoar and 20g of borneol into fine powder; decocting 180g of gypsum, 130g of astragalus, 80g of platycodon grandiflorum, 40g of liquorice and 20g of dandelion with water twice for 2 hours each time, filtering, combining the two filtrates, concentrating the filtrate into clear paste, adding rheum officinale powder and realgar powder, uniformly stirring, granulating, drying, adding calculus bovis powder and borneol powder, uniformly stirring, and tabletting to obtain a plain tablet; spraying the coating solution in preparation example 7 on plain tablet, and drying to obtain detoxicating tablet.
Comparative example 3
Comparative example 3 provides a preparation method of a cattle yellow detoxification tablet, comprising the following steps: grinding 185g of rheum officinale, 40g of realgar, 3g of bezoar and 20g of borneol into fine powder; decocting 185g of gypsum, 135g of astragalus, 85g of platycodon grandiflorum and 40g of liquorice with water twice for 2 hours each time, filtering, combining the two filtrates, concentrating the filtrate into clear paste, adding rhubarb powder, realgar powder and 5kg of cordate houttuynia extract in preparation example 1, uniformly stirring, granulating, drying, adding bezoar powder and borneol powder, uniformly stirring, and tabletting to obtain a plain tablet; spraying the coating solution in preparation example 7 on plain tablet, and drying to obtain detoxicating tablet.
Performance test
(1) The muscle soreness treatment effect: 40 patients with internal heat and muscular soreness are selected, the ages are selected from 20-65 years, every ten people is one group, the patients are divided into four groups, the bezoar detoxification tablets in the example 1 and the comparative examples 1-3 are respectively detected, 3 times a day and 3 tablets at a time are taken for three days, and the number of people with improved muscular soreness symptoms of the patients is obtained.
(2) Dissolution rate: the dissolution rate of flavone in the bezoar detoxification tablet is measured by detecting the bezoar detoxification tablet in each embodiment, and the higher the dissolution rate is, the better the curative effect of the bezoar detoxification tablet is.
(3) Moisture resistance: the detoxicating tablet of calculus bovis in each example was placed in an open clean container, and left in a constant temperature and humidity environment, and the surface of the detoxicating tablet was observed after two weeks.
TABLE 3 detection results of detoxicating tablet of bezoar
Figure BDA0004189066810000061
Figure BDA0004189066810000071
By combining the embodiment 1 with the comparative examples 1-3, the dissolution rate of the flavone in the bezoar detoxification tablet in the embodiment 1 is the highest, and the bezoar detoxification tablet has a certain treatment effect on muscle soreness, and the addition of the dandelion and the houttuynia cordata extracts simultaneously in the preparation of the bezoar detoxification tablet can not only improve the drug effect of the bezoar detoxification tablet, but also ensure that the bezoar detoxification tablet has the treatment effect on muscle soreness.
In combination with examples 1 to 3, the dissolution rate of flavone in the detoxicating tablet of example 2 is highest, and it can be seen that the extraction condition of herba Houttuyniae in example 2 is best when herba Houttuyniae is extracted.
By combining the embodiment 1 and the embodiment 6, the dissolution rate of the flavone in the bezoar detoxification tablet in the embodiment 1 is higher, and the addition of the polyethoxy lauric acid herbal tea alcohol can improve the extraction effect of the houttuynia cordata when the houttuynia cordata is extracted, so that the dissolution rate of the bezoar detoxification tablet is improved.
In combination of examples 2, 4 and 5, the dissolution rate of flavone in the detoxicating tablet of example 4 is highest, and it can be seen that increasing the consumption of polyethoxy lauric acid and cooling tea alcohol when herba Houttuyniae is extracted, the extraction effect of herba Houttuyniae tends to increase and decrease.
In combination with examples 4 and examples 7 to 10, the bezoar detoxification tablet in examples 7 to 9 has better anti-wetting performance, and the preferable proportion of magnesium stearate, titanium pigment, hypromellose, acrylic resin and ethanol is 1: (8-10): (10-20): (8-10): (80-120), the coating liquid has good coating effect, so that the anti-wetting performance of the bezoar detoxicated tablet is improved.
By combining the embodiment 8, the embodiment 11 and the embodiment 12, the dissolution rate of the flavone in the bezoar detoxification tablet in the embodiment 11 is highest, and the trend that the curative effect of the bezoar detoxification tablet is improved and then reduced after the use amount of raw materials is increased when the bezoar detoxification tablet is prepared is seen.
The present embodiment is merely illustrative of the present application and is not intended to be limiting, and those skilled in the art, after having read the present specification, may make modifications to the present embodiment without creative contribution as required, but is protected by patent laws within the scope of the claims of the present application.

Claims (8)

1. A cattle yellow detoxification tablet, which is characterized in that: the raw materials of the detoxification tablet comprise the following components in parts by weight: 3-8 parts of bezoar, 180-220 parts of gypsum, 130-170 parts of astragalus, 20-30 parts of borneol, 40-60 parts of realgar, 180-220 parts of rheum officinale, 80-120 parts of platycodon grandiflorum, 40-60 parts of liquorice, 20-40 parts of dandelion and 5-15 parts of cordate houttuynia extract.
2. The cattle yellow detoxification tablet according to claim 1, wherein: the preparation method of the houttuynia cordata extract comprises the following steps:
pulverizing herba Houttuyniae to obtain herba Houttuyniae powder, adding polyethoxy lauric acid and herbal tea alcohol into herba Houttuyniae powder, stirring, mixing, adding ethanol solution, stirring to obtain mixed solution, extracting in water bath, layering, concentrating supernatant, and drying to obtain herba Houttuyniae extract.
3. The cattle yellow detoxification tablet according to claim 2, wherein: the water bath extraction temperature of the mixed solution is 60-80 ℃ and the extraction time is 50-60min.
4. The cattle yellow detoxification tablet according to claim 2, wherein: the mass concentration of the polyethoxy lauric acid cool tea alcohol in the mixed solution is 0.5-1.5g/L.
5. A method for preparing the bezoar detoxification tablet according to any one of claims 1-4, wherein: the method comprises the following steps:
grinding radix et rhizoma Rhei, realgar, calculus bovis, and Borneolum Syntheticum into fine powder; decocting Gypsum Fibrosum, radix astragali, radix Platycodi, glycyrrhrizae radix and herba Taraxaci in water twice, filtering, mixing the filtrates, concentrating the filtrate to obtain fluid extract, adding radix et rhizoma Rhei powder, realgar powder and herba Houttuyniae extract, stirring, granulating, drying, adding calculus bovis powder and Borneolum Syntheticum powder, stirring, and tabletting to obtain tablet; spraying the coating solution on the tablet, and drying to obtain the detoxicating tablet.
6. The method for preparing the cattle yellow detoxification tablet according to claim 5, wherein the method comprises the following steps: the preparation method of the coating liquid comprises the following steps:
sequentially adding acrylic resin and hypromellose into medicinal ethanol, stirring, adding titanium dioxide and magnesium stearate after the hypromellose is dissolved, and stirring and mixing to obtain coating solution.
7. The method for preparing the cattle yellow detoxification tablet according to claim 6, wherein the method comprises the following steps: the weight ratio of the magnesium stearate to the titanium dioxide to the hydroxypropyl methylcellulose to the acrylic resin to the ethanol is 1: (8-10): (10-20): (8-10): (80-120).
8. The method for preparing the cattle yellow detoxification tablet according to claim 5, wherein the method comprises the following steps: decocting Gypsum Fibrosum, radix astragali, radix Platycodi, glycyrrhrizae radix and herba Taraxaci in water for 1.5-2.5 hr twice.
CN202310427458.4A 2023-04-20 2023-04-20 Cattle yellow detoxification tablet and preparation method thereof Pending CN116370543A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310427458.4A CN116370543A (en) 2023-04-20 2023-04-20 Cattle yellow detoxification tablet and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310427458.4A CN116370543A (en) 2023-04-20 2023-04-20 Cattle yellow detoxification tablet and preparation method thereof

Publications (1)

Publication Number Publication Date
CN116370543A true CN116370543A (en) 2023-07-04

Family

ID=86976761

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310427458.4A Pending CN116370543A (en) 2023-04-20 2023-04-20 Cattle yellow detoxification tablet and preparation method thereof

Country Status (1)

Country Link
CN (1) CN116370543A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101612136A (en) * 2008-06-23 2009-12-30 株洲千金药业股份有限公司 A kind of Chinese medicinal tablet thin film coating material and preparation method thereof
CN101991659A (en) * 2009-08-11 2011-03-30 汤明昌 Preparation with functions of clearing heat and releasing toxin and preparation method
CN103006803A (en) * 2012-11-23 2013-04-03 郑州瑞龙制药股份有限公司 Preparation method of detoxicating tablet of cow-bezoar
CN103494929A (en) * 2013-10-09 2014-01-08 南京农业大学 Houttuynia cordata injectable in situ gel as well as preparation method thereof
CN106880669A (en) * 2015-12-12 2017-06-23 天津中新药业集团股份有限公司隆顺榕制药厂 A kind of clearing heat and detoxicating Chinese medicine composition and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101612136A (en) * 2008-06-23 2009-12-30 株洲千金药业股份有限公司 A kind of Chinese medicinal tablet thin film coating material and preparation method thereof
CN101991659A (en) * 2009-08-11 2011-03-30 汤明昌 Preparation with functions of clearing heat and releasing toxin and preparation method
CN103006803A (en) * 2012-11-23 2013-04-03 郑州瑞龙制药股份有限公司 Preparation method of detoxicating tablet of cow-bezoar
CN103494929A (en) * 2013-10-09 2014-01-08 南京农业大学 Houttuynia cordata injectable in situ gel as well as preparation method thereof
CN106880669A (en) * 2015-12-12 2017-06-23 天津中新药业集团股份有限公司隆顺榕制药厂 A kind of clearing heat and detoxicating Chinese medicine composition and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘芸等: "基于鱼腥草的体内外抗氧化活性研究", 山西化工, vol. 42, no. 9, pages 18 - 20 *
尹晓飞;王立华;王永利;李冬梅;蔡大伟;李慧;: "牛黄解毒滴丸及其制备方法", 中国医院药学杂志, vol. 27, no. 02, pages 257 - 258 *
钟才明: "牛黄解毒滴丸联合溃疡散治疗口腔溃疡27例临床观察", 中国民族民间医药, vol. 24, no. 17, pages 108 *
魏荣, 冯超英, 于峰, 王庶: "小汤山医院680名SARS患者药物治疗分析", 中医药临床杂志, vol. 16, no. 05, pages 407 - 409 *

Similar Documents

Publication Publication Date Title
CN104887952B (en) Composition with yin nourishing and lung moistening effects and preparation method and application thereof
CN103007012B (en) Traditional Chinese medicine composition for treating toothaches and preparation method thereof
CN101085079A (en) Traditional Chinese medicine compound for treating diabetes and its preparation method and application
CN104013929A (en) Rheumatism pain relief medicine for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof
CN104352793A (en) Traditional Chinese medicine preparation for treating gastrointestinal bleeding and preparation method thereof
CN107890528B (en) Traditional Chinese medicine composition for treating hyperuricemia and preparation method thereof
CN116370543A (en) Cattle yellow detoxification tablet and preparation method thereof
CN108186821B (en) Traditional Chinese medicine composition for treating nervous headache and preparation method and application thereof
CN112717097A (en) Traditional Chinese medicine composition for treating gastric cancer and preparation method thereof
CN105521332A (en) Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof
CN105232958A (en) Traditional Chinese medicine combination for preparing medicine for treating myasthenia gravis
CN104352672A (en) Tortoise plastron-containing traditional Chinese medicine composition for treating diabetes
CN112618425A (en) Preparation method of multi-effect repairing, moistening and hair nourishing essence
CN115252729B (en) Traditional Chinese medicine composition for treating diabetes and application thereof
CN116270830B (en) Anti-radiation traditional Chinese medicine composition and application thereof
CN114588240B (en) Traditional Chinese medicine composition for treating colorectal cancer and preparation method and application thereof
CN101322788B (en) Chinese medicine for treating vitiligo and preparation
CN108653460B (en) Traditional Chinese medicine composition for treating chronic urticaria and preparation method thereof
CN104096065A (en) Traditional Chinese medicine composition for treating non-small cell lung cancer
CN106692698B (en) Bletilla striata cough relieving granule and preparation method thereof
CN106334140A (en) Traditional Chinese medicine composition and preparation method thereof
CN105012391B (en) Medicine for treating viral influenza and preparation method thereof
CN104826080A (en) Traditional Chinese medicine preparation for treating angina pectoris
CN104147202B (en) Benefiting qi and nourishing blood, toxin expelling Fructus Alpiniae Oxyphyllae, Yin Yang balancing, the microcirculatory compositions of improvement and preparation thereof
CN104784628A (en) Traditional Chinese medicine composition for treating hepatitis B

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination